Compare Berkshire Hathaway Inc Class B (BRK.B) vs Hims and Hers Health Inc (HIMS) Price & Performance

BRK.B trades at $490.00, down 1.37% on the day. The technical picture shows a bullish moving average signal but neutral oscillators, with immediate support at $489 and resistance at $495. Analyst consensus is bullish with 57% buy ratings and no sell recommendations. The stock's valuation metrics are not provided in the current dataset.

The outlook is cautiously positive based on analyst sentiment and technical positioning near support. Key risks include market volatility and the company's exposure to broad economic cycles. The absence of current fundamental data necessitates direct review of Berkshire Hathaway's latest SEC filings for a complete investment picture.

Hims & Hers Health trades at $34.38, showing no change in the last session. The stock exhibits a bullish technical setup with moving averages supporting upward momentum, while oscillators remain neutral. Recent earnings have been mixed, with Q1 2026 missing expectations, but revenue growth remains positive. Analyst sentiment is divided with a 35% buy rating, and the consensus price target is $33.57. News highlights include expansion in weight-loss treatments and a new JPMorgan receivables facility.

The outlook for HIMS is cautiously optimistic, driven by growth in telehealth and weight-loss segments, but high valuation multiples and recent net income declines pose risks. Investment opportunity lies in market expansion and subscriber growth, while execution risks and competitive pressures require monitoring.